Search results for "ffpe challenges"

New proprietary assembly technology pairs with groundbreaking complex DNA synthesis platform to deliver sequence-perfect clonal DNA as long as 5 kb

Global provider of gene editing and personalized medicine technologies has launched a service for high-throughput gene expression analysis

Sample preparation solutions for unique applications and difficult samples

DNA polymerase included, Complete Kit with optimized enzyme to amplify total RNA in <4 hours, no 3′ bias

Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.

Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.

Automated immunoassays and component-level testing support more precise allergy diagnostics

2026 Surviving Sepsis Campaign Guidelines and U.S. SEPSIS Act reinforce the need to close persistent therapeutic gaps in septic shock and improve survival through personalized, evidence-based approaches

Discover how Dr. Vasiliki E Kalodimou uses advanced flow cytometry to bridge the gap between laboratory precision and personalized biotherapies for Lab Professionals Week 2026

In an era where algorithmic hypothesis generation outpaces experimental validation capacity, the Centre of Excellence positions Arctoris at the critical interface between computational design and empirical truth

Major vendors unveil new instruments and workflow solutions, highlighting a continued focus on performance, integration, and data-driven analysis

Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics

The innovative instrument helps clinical flow cytometry labs automate end-to-end sample preparation

New centrifuge options accommodate speeds up to 110,000 x g and capacities up to six liters

The VENTANA MMR RxDx Panel is the first and only immunohistochemistry-based assay approved to identify endometrial carcinoma patients eligible for treatment with JEMPERLI (dostarlimab).